2013
DOI: 10.1186/1471-2482-13-38
|View full text |Cite
|
Sign up to set email alerts
|

The effect of ursodeoxycholic acid in liver functional restoration of patients with obstructive jaundice after endoscopic treatment: a prospective, randomized, and controlled study

Abstract: BackgroundIn patients with obstructive jaundice, multi-organ dysfunction may develop.Methods/DesignThis trial is a prospective, open-label, randomized, and controlled study with the objective to evaluate the effect of ursodeoxycholic acid in liver functional restoration in patients with obstructive jaundice after endoscopic treatment. The aim of this study is to evaluate the effect of ursodeoxycholic acid in liver functional restoration of patients with obstructive jaundice after endoscopic treatment. The hypo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0
1

Year Published

2014
2014
2021
2021

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 19 publications
0
4
0
1
Order By: Relevance
“…In primary rat hepatocytes, UDCA was shown to downregulate p53 expression and prevent apoptosis signaling through reduction of Bcl- 2(B-cell lymphoma 2) associated X protein (Bax) expression, mitochondrial translocation, and cytochrome c release [14]. Clinical studies showed that UDCA intervention was able to restore the liver function of obstructive jaundice patients after endoscopic treatment [75]. Intrahepatic cholestasis (ICP) is a pregnancy liver disorder that is reported to affect pregnancy during the third trimester and is mostly treated with UDCA.…”
Section: The Most Hydrophilic Bile Acids—ursodeoxycholic Acidmentioning
confidence: 99%
“…In primary rat hepatocytes, UDCA was shown to downregulate p53 expression and prevent apoptosis signaling through reduction of Bcl- 2(B-cell lymphoma 2) associated X protein (Bax) expression, mitochondrial translocation, and cytochrome c release [14]. Clinical studies showed that UDCA intervention was able to restore the liver function of obstructive jaundice patients after endoscopic treatment [75]. Intrahepatic cholestasis (ICP) is a pregnancy liver disorder that is reported to affect pregnancy during the third trimester and is mostly treated with UDCA.…”
Section: The Most Hydrophilic Bile Acids—ursodeoxycholic Acidmentioning
confidence: 99%
“…Непрерывная заместительная почечная терапия и прерывистый гемодиализ эффективны у пациентов с тяжелым сепсисом и острой почечной недостаточностью. Плазмосорбция и плазмофильтрация снижают уровень билирубина и других токсических метаболитов, образующихся на фоне МЖ и холестаза, но пролонгированный эффект отмечается только при адекватной билиарной декомпрессии [44][45][46].…”
Section: раздел 2 консервативные методы лечения больных с мжunclassified
“…Clinical studies show that UDCA intervention able to restore the liver function of obstructive jaundice patients after the endoscopic treatment [86]. Intrahepatic cholestasis (ICP) is a pregnancy liver disorder reported to affect pregnancy during the third trimester and mostly treated with UDCA.…”
Section: Udca As a Therapeutic Agentmentioning
confidence: 99%